Logo image of 1ROG.MI

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Fundamental Analysis

BIT:1ROG - CH0012032048 - Common Stock

278 EUR
+4 (+1.46%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

6

1ROG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 50 industry peers in the Pharmaceuticals industry. 1ROG gets an excellent profitability rating and is at the same time showing great financial health properties. 1ROG has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year 1ROG was profitable.
1ROG had a positive operating cash flow in the past year.
In the past 5 years 1ROG has always been profitable.
1ROG had a positive operating cash flow in each of the past 5 years.
1ROG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ROG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

The Return On Assets of 1ROG (8.13%) is better than 70.00% of its industry peers.
1ROG has a Return On Equity of 26.06%. This is in the better half of the industry: 1ROG outperforms 78.00% of its industry peers.
With an excellent Return On Invested Capital value of 22.12%, 1ROG belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1ROG is significantly above the industry average of 15.89%.
Industry RankSector Rank
ROA 8.13%
ROE 26.06%
ROIC 22.12%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1ROG.MI Yearly ROA, ROE, ROIC1ROG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

1ROG has a Profit Margin of 13.68%. This is comparable to the rest of the industry: 1ROG outperforms 60.00% of its industry peers.
1ROG's Profit Margin has declined in the last couple of years.
1ROG's Operating Margin of 33.20% is amongst the best of the industry. 1ROG outperforms 82.00% of its industry peers.
In the last couple of years the Operating Margin of 1ROG has remained more or less at the same level.
1ROG has a Gross Margin of 73.91%. This is in the better half of the industry: 1ROG outperforms 66.00% of its industry peers.
1ROG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.2%
PM (TTM) 13.68%
GM 73.91%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
1ROG.MI Yearly Profit, Operating, Gross Margins1ROG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

1ROG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1ROG has been reduced compared to 1 year ago.
1ROG has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1ROG has a worse debt to assets ratio.
1ROG.MI Yearly Shares Outstanding1ROG.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1ROG.MI Yearly Total Debt VS Total Assets1ROG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

An Altman-Z score of 3.80 indicates that 1ROG is not in any danger for bankruptcy at the moment.
1ROG has a Altman-Z score (3.80) which is comparable to the rest of the industry.
1ROG has a debt to FCF ratio of 2.30. This is a good value and a sign of high solvency as 1ROG would need 2.30 years to pay back of all of its debts.
1ROG's Debt to FCF ratio of 2.30 is fine compared to the rest of the industry. 1ROG outperforms 78.00% of its industry peers.
1ROG has a Debt/Equity ratio of 0.98. This is a neutral value indicating 1ROG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.98, 1ROG is in line with its industry, outperforming 42.00% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for 1ROG, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 2.3
Altman-Z 3.8
ROIC/WACC4.68
WACC4.73%
1ROG.MI Yearly LT Debt VS Equity VS FCF1ROG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.48 indicates that 1ROG should not have too much problems paying its short term obligations.
1ROG has a Current ratio of 1.48. This is in the better half of the industry: 1ROG outperforms 66.00% of its industry peers.
1ROG has a Quick Ratio of 1.20. This is a normal value and indicates that 1ROG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.20, 1ROG is doing good in the industry, outperforming 76.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.2
1ROG.MI Yearly Current Assets VS Current Liabilites1ROG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

3

3. Growth

3.1 Past

1ROG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.19%.
Measured over the past years, 1ROG shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.39% on average per year.
Looking at the last year, 1ROG shows a small growth in Revenue. The Revenue has grown by 3.03% in the last year.
The Revenue has been decreasing by -0.32% on average over the past years.
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%

3.2 Future

1ROG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.37% yearly.
The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y10.74%
EPS Next 2Y8.48%
EPS Next 3Y7.4%
EPS Next 5Y6.37%
Revenue Next Year2.74%
Revenue Next 2Y2.91%
Revenue Next 3Y3.09%
Revenue Next 5Y3.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ROG.MI Yearly Revenue VS Estimates1ROG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
1ROG.MI Yearly EPS VS Estimates1ROG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.22 indicates a correct valuation of 1ROG.
68.00% of the companies in the same industry are more expensive than 1ROG, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.17, 1ROG is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 11.75, the valuation of 1ROG can be described as reasonable.
68.00% of the companies in the same industry are more expensive than 1ROG, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.78. 1ROG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.22
Fwd PE 11.75
1ROG.MI Price Earnings VS Forward Price Earnings1ROG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

64.00% of the companies in the same industry are more expensive than 1ROG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ROG indicates a somewhat cheap valuation: 1ROG is cheaper than 78.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.95
EV/EBITDA 9.23
1ROG.MI Per share data1ROG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1ROG may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)N/A
EPS Next 2Y8.48%
EPS Next 3Y7.4%

5

5. Dividend

5.1 Amount

1ROG has a Yearly Dividend Yield of 3.77%.
1ROG's Dividend Yield is a higher than the industry average which is at 2.97.
1ROG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.77%

5.2 History

The dividend of 1ROG has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

97.17% of the earnings are spent on dividend by 1ROG. This is not a sustainable payout ratio.
1ROG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP97.17%
EPS Next 2Y8.48%
EPS Next 3Y7.4%
1ROG.MI Yearly Income VS Free CF VS Dividend1ROG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1ROG.MI Dividend Payout.1ROG.MI Dividend Payout, showing the Payout Ratio.1ROG.MI Dividend Payout.PayoutRetained Earnings

ROCHE HOLDING AG-GENUSSCHEIN

BIT:1ROG (8/22/2025, 7:00:00 PM)

278

+4 (+1.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-23 2025-10-23
Inst Owners37.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap224.97B
Analysts71.11
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.77%
Yearly Dividend10.85
Dividend Growth(5Y)2.37%
DP97.17%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.22
Fwd PE 11.75
P/S 3.48
P/FCF 13.95
P/OCF 10.47
P/B 6.62
P/tB 31.94
EV/EBITDA 9.23
EPS(TTM)21.03
EY7.56%
EPS(NY)23.65
Fwd EY8.51%
FCF(TTM)19.93
FCFY7.17%
OCF(TTM)26.55
OCFY9.55%
SpS79.93
BVpS41.97
TBVpS8.7
PEG (NY)1.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.13%
ROE 26.06%
ROCE 26.86%
ROIC 22.12%
ROICexc 28.73%
ROICexgc 50.83%
OM 33.2%
PM (TTM) 13.68%
GM 73.91%
FCFM 24.94%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexcg growth 3Y2.54%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score6
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 2.3
Debt/EBITDA 1.33
Cap/Depr 146.33%
Cap/Sales 8.28%
Interest Coverage 17.54
Cash Conversion 85.47%
Profit Quality 182.25%
Current Ratio 1.48
Quick Ratio 1.2
Altman-Z 3.8
F-Score6
WACC4.73%
ROIC/WACC4.68
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
EPS Next Y10.74%
EPS Next 2Y8.48%
EPS Next 3Y7.4%
EPS Next 5Y6.37%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
Revenue Next Year2.74%
Revenue Next 2Y2.91%
Revenue Next 3Y3.09%
Revenue Next 5Y3.81%
EBIT growth 1Y8.41%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year26.38%
EBIT Next 3Y10.93%
EBIT Next 5Y9.32%
FCF growth 1Y31.79%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y24.85%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%